期刊
JOURNAL OF ALZHEIMERS DISEASE
卷 75, 期 4, 页码 1241-1252出版社
IOS PRESS
DOI: 10.3233/JAD-200232
关键词
Amyloid; middle age; Hispanic; type 2 diabetes
资金
- National Institutes of Health [R01AG050440, RF1AG051556, K24AG045334, P30AG059303, ULT1TR001873]
Background: Type 2 diabetes is a dementia risk factor, but its relation to Alzheimer's disease (AD), the most common cause of dementia, is unclear. Objective: Our primary objective was to examine the association of pre-diabetes and type 2 diabetes with brain amyloid-B (AB), the putative main culprit of AD. Our secondary objective was to examine the association of pre-diabetes and type 2 diabetes with neurodegeneration, cerebrovascular disease (CVD), and memory performance. Methods: We conducted a cross-sectional study of 350 late middle-aged Hispanics without dementia in New York City. We classified diabetes status as normal glucose tolerance (NGT), pre-diabetes, and type 2 diabetes following American Diabetes Association criteria. Brain AB was ascertained as global AB standardized value uptake ratio using PET with 18 F-Florbetaben. Neurodegeneration was operationalized as cortical thickness in regions affected by AD using MRI. CVD was operationalized as white matter hyperintensity volume (WMH) on MRI, and memory as performance with the selective reminding test (SRT). Results: Mean age was 64.15 +/- 3.34 years, 72.00% were women, and 35.43% were APOE 84 carriers. Pre-diabetes, but not type 2 diabetes, was associated with higher AB compared with NGT. Type 2 diabetes treatment was related to lower AB. Type 2 diabetes was related to lower cortical thickness, higher WMH, and lower SRT score. Conclusion: Pre-diabetes, but not type 2 diabetes, is associated with higher brain AB in late middle age, and this observation could be explained by the relation of diabetes treatment with lower brain AB. Whether type 2 diabetes treatment lowers brain AB requires further study.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据